You are currently on the new version of our website. Access the old version .

Cancers, Volume 10, Issue 12

2018 December - 65 articles

Cover Story: The resistance of cancer cells to commonly used therapeutics is a key clinical challenge. The behaviour of cancer cells is influenced by their environment, which evolves along with tumor progression. Chemoresistance can be stimulated by elements of the tumor microenvironment, including extracellular matrix proteins, hypervascularization, hypoxia, and paracrine factors. This environment is generated by cancer cells and other associated cells, and is notable for its self-maintenance behaviour, which exacerbates tumor development. Through a network of interactions, environmental cues promote cancer cell proliferation and the epithelial–mesenchymal transition, and affect drug availability, leading to a chemoresistant phenotype. This review discusses the self-perpetuating tumor microenvironment and its effects on chemoresistance. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (65)

  • Article
  • Open Access
9 Citations
6,248 Views
15 Pages

RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective

  • Joakim Crona,
  • Samuel Backman,
  • Staffan Welin,
  • David Taïeb,
  • Per Hellman,
  • Peter Stålberg,
  • Britt Skogseid and
  • Karel Pacak

15 December 2018

Adrenocortical carcinoma (ACC) and pheochromocytoma and paraganglioma (PPGL) are defined by clinicopathological criteria and can be further sub-divided based on different molecular features. Whether differences between these molecular subgroups are s...

  • Review
  • Open Access
20 Citations
7,701 Views
16 Pages

14 December 2018

Germ-line mutations in breast cancer susceptibility gene 1 (BRCA1) predominantly predispose women to breast and ovarian cancers. BRCA1 is best known for its functions in maintenance of genomic integrity including repairing DNA double-strand breaks th...

  • Review
  • Open Access
177 Citations
16,197 Views
19 Pages

14 December 2018

Triple negative breast cancer (TNBC) is a molecularly heterogeneous disease whose incidence is disproportionately higher in African American (AA) women compared to European American (EA) women. Earlier onset, more advanced stage at diagnosis, and agg...

  • Review
  • Open Access
22 Citations
5,726 Views
24 Pages

14 December 2018

Recent development in radiation biology has revealed potent immunogenic properties of radiotherapy in cancer treatments. However, antitumor immune effects of radiotherapy are limited by the concomitant induction of radiation-dependent immunosuppressi...

  • Article
  • Open Access
37 Citations
5,036 Views
12 Pages

Combination Therapy after TACE for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: Stereotactic Body Radiotherapy versus Sorafenib

  • Lujun Shen,
  • Mian Xi,
  • Lei Zhao,
  • Xuhui Zhang,
  • Xiuchen Wang,
  • Zhimei Huang,
  • Qifeng Chen,
  • Tianqi Zhang,
  • Jingxian Shen and
  • Jinhua Huang
  • + 1 author

14 December 2018

Stereotactic body radiotherapy (SBRT) has shown promising results in the control of macroscopic vascular invasion in patients with hepatocellular carcinoma (HCC); however, its efficacy in comparison to sorafenib when combined with transarterial chemo...

  • Article
  • Open Access
61 Citations
5,330 Views
17 Pages

13 December 2018

Glioblastoma multiforme (GBM) requires radiotherapy (RT) as a part of definitive management strategy. RT is highly effective, destroying cancer cells that may exist around the surgical tumor bed. However, GBM still has a poor prognosis and a high loc...

  • Review
  • Open Access
63 Citations
7,409 Views
14 Pages

Management of Typical and Atypical Pulmonary Carcinoids Based on Different Established Guidelines

  • Rohit Gosain,
  • Sarbajit Mukherjee,
  • Sai S. Yendamuri and
  • Renuka Iyer

12 December 2018

Neuroendocrine tumors (NETs) are a group of malignancies that originated from neuroendocrine cells, with the most common sites being lungs and the gastrointestinal tract. Lung NETs comprise 25% of all lung malignancies. Small cell lung cancer is the...

  • Article
  • Open Access
4 Citations
3,761 Views
16 Pages

Mitochondrial Hyperactivation and Enhanced ROS Production are Involved in Toxicity Induced by Oncogenic Kinases Over-Signaling

  • Monica Ceccon,
  • Mario Mauri,
  • Luca Massimino,
  • Giovanni Giudici,
  • Rocco Piazza,
  • Carlo Gambacorti-Passerini and
  • Luca Mologni

12 December 2018

Targeted therapy is an effective, rational, and safe approach to solid and hematological tumors treatment. Unfortunately, a significant fraction of patients treated with tyrosine kinase inhibitors (TKI) relapses mainly because of gene amplification,...

  • Article
  • Open Access
16 Citations
5,366 Views
26 Pages

Use of Germline Genetic Variability for Prediction of Chemoresistance and Prognosis of Breast Cancer Patients

  • Viktor Hlavac,
  • Maria Kovacova,
  • Katerina Elsnerova,
  • Veronika Brynychova,
  • Renata Kozevnikovova,
  • Karel Raus,
  • Katerina Kopeckova,
  • Sona Mestakova,
  • David Vrana and
  • Pavel Soucek
  • + 3 authors

12 December 2018

The aim of our study was to set up a panel for targeted sequencing of chemoresistance genes and the main transcription factors driving their expression and to evaluate their predictive and prognostic value in breast cancer patients. Coding and regula...

  • Article
  • Open Access
26 Citations
5,136 Views
17 Pages

Intracellular Iron Chelation by a Novel Compound, C7, Reactivates Epstein–Barr Virus (EBV) Lytic Cycle via the ERK-Autophagy Axis in EBV-Positive Epithelial Cancers

  • Stephanie Pei Tung Yiu,
  • Kwai Fung Hui,
  • Chung King Choi,
  • Richard Yi Tsun Kao,
  • Chi Wang Ma,
  • Dan Yang and
  • Alan Kwok Shing Chiang

11 December 2018

Pharmaceutical reactivation of lytic cycle of Epstein–Barr virus (EBV) represents a potential therapeutic strategy against EBV-associated epithelial malignancies, e.g., gastric carcinoma (GC) and nasopharyngeal carcinoma (NPC). A novel lytic-in...

of 7

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694